Literature DB >> 12647278

Antihyperglycemic and blood pressure-reducing effects of stevioside in the diabetic Goto-Kakizaki rat.

P B Jeppesen1, S Gregersen, S E D Rolfsen, M Jepsen, M Colombo, A Agger, J Xiao, M Kruhøffer, T Orntoft, K Hermansen.   

Abstract

Stevioside, a glycoside present in the leaves of the plant, Stevia rebaudiana Bertoni (SrB), has acute insulinotropic effects in vitro. Its potential antihyperglycemic and blood pressure-lowering effects were examined in a long-term study in the type 2 diabetic Goto-Kakizaki (GK) rat. Rats were fed 0.025 g x kg(-1) x d(-1) of stevioside (purity > 99.6%) for 6 weeks. An intra-arterial catheter was inserted into the rats after 5 weeks, and conscious rats were subjected to arterial glucose tolerance test (2.0 g x kg(-1)) during week 6. Stevioside had an antihyperglycemic effect (incremental area under the glucose response curve [IAUC]): 985 +/- 20 (stevioside) versus 1,575 +/- 21 (control) mmol/L x 180 minutes, (P <.05), it enhanced the first-phase insulin response (IAUC: 343 +/- 33 [stevioside] v 136 +/- 24 [control] microU/mL insulin x 30 minutes, P <.05) and concomitantly suppressed the glucagon levels (total AUC: 2,026 +/- 234 [stevioside] v 3,535 +/- 282 [control] pg/mL x 180 minutes, P <.05). In addition, stevioside caused a pronounced suppression of both the systolic (135 +/- 2 v 153 +/- 5 mm Hg; P <.001) and the diastolic blood pressure (74 +/- 1 v 83 +/- 1 mm Hg; P <.001). Bolus injections of stevioside (0.025 g x kg(-1)) did not induce hypoglycemia. Stevioside augmented the insulin content in the beta-cell line, INS-1. Stevioside may increase the insulin secretion, in part, by induction of genes involved in glycolysis. It may also improve the nutrient-sensing mechanisms, increase cytosolic long-chain fatty acyl-coenzyme A (CoA), and downregulate phosphodiesterase 1 (PDE1) estimated by the microarray gene chip technology. In conclusion, stevioside enjoys a dual positive effect by acting as an antihyperglycemic and a blood pressure-lowering substance; effects that may have therapeutic potential in the treatment of type 2 diabetes and the metabolic syndrome. Copyright 2003, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12647278     DOI: 10.1053/meta.2003.50058

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  34 in total

1.  Hypoglycaemic action of stevioside and а barley and brewer's yeast based preparation in the experimental model on mice.

Authors:  Vlada Cekic; Velibor Vasovic; Vida Jakovljevic; Momir Mikov; Ana Sabo
Journal:  Bosn J Basic Med Sci       Date:  2011-02       Impact factor: 3.363

Review 2.  Stevia rebaudiana Bertoni: A Natural Alternative for Treating Diseases Associated with Metabolic Syndrome.

Authors:  Areli Carrera-Lanestosa; Yolanda Moguel-Ordóñez; Maira Segura-Campos
Journal:  J Med Food       Date:  2017-08-09       Impact factor: 2.786

3.  Interactions of stevioside and steviol with renal organic anion transporters in S2 cells and mouse renal cortical slices.

Authors:  Chutima Srimaroeng; Promsuk Jutabha; John B Pritchard; Hitoshi Endou; Varanuj Chatsudthipong
Journal:  Pharm Res       Date:  2005-06-08       Impact factor: 4.200

4.  Beneficial effects of Stevioside on AGEs, blood glucose, lipid profile and renal status in streptozotocin-induced diabetic rats.

Authors:  Urmila Aswar; Vinayak Gogawale; Pankaj Miniyar; Yugendra Patil
Journal:  J Appl Biomed       Date:  2019-08-21       Impact factor: 1.797

5.  The diterpene glycoside, rebaudioside A, does not improve glycemic control or affect blood pressure after eight weeks treatment in the Goto-Kakizaki rat.

Authors:  Stig E U Dyrskog; Per B Jeppesen; Jianguo Chen; Lars P Christensen; Kjeld Hermansen
Journal:  Rev Diabet Stud       Date:  2005-08-10

6.  Stevioside Counteracts Beta-Cell Lipotoxicity without Affecting Acetyl CoA Carboxylase.

Authors:  Jianguo Chen; Per Bendix Jeppesen; Iver Nordentoft; Kjeld Hermansen
Journal:  Rev Diabet Stud       Date:  2007-02-10

7.  Can stevioside in combination with a soy-based dietary supplement be a new useful treatment of type 2 diabetes? An in vivo study in the diabetic goto-kakizaki rat.

Authors:  Per B Jeppesen; Stig E Dyrskog; Andreas Agger; Soren Gregersen; Michele Colombo; Jianzhong Xiao; Kjeld Hermansen
Journal:  Rev Diabet Stud       Date:  2007-02-10

Review 8.  Stevia rebaudiana Bertoni and Its Effects in Human Disease: Emphasizing Its Role in Inflammation, Atherosclerosis and Metabolic Syndrome.

Authors:  Edward Rojas; Valmore Bermúdez; Yasaman Motlaghzadeh; Justin Mathew; Enzamaria Fidilio; Judith Faria; Joselyn Rojas; Mayela Cabrera de Bravo; Julio Contreras; Linda Pamela Mantilla; Lissé Angarita; Paola Amar Sepúlveda; Isaac Kuzmar
Journal:  Curr Nutr Rep       Date:  2018-07-11

9.  Isosteviol has beneficial effects on palmitate-induced α-cell dysfunction and gene expression.

Authors:  Xiaoping Chen; Kjeld Hermansen; Jianzhong Xiao; Sara Kjaergaard Bystrup; Lorraine O'Driscoll; Per Bendix Jeppesen
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

10.  Brain glucose sensors play a significant role in the regulation of pancreatic glucose-stimulated insulin secretion.

Authors:  Mayowa A Osundiji; Daniel D Lam; Jill Shaw; Chen-Yu Yueh; S Pauliina Markkula; Paul Hurst; Carolina Colliva; Aldo Roda; Lora K Heisler; Mark L Evans
Journal:  Diabetes       Date:  2011-12-30       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.